Log In
BCIQ
Print this Print this
 

LiquidBiopsy

  Manage Alerts
Collapse Summary General Information
Company Cynvenio Biosystems Inc.
DescriptionDiagnostic to perform sequence analysis and genomic reporting on rare populations of circulating tumor cells (CTCs) and cell-free DNA from whole blood
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/19/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today